(VIANEWS) – eXp World Holdings (EXPI), Danaos Corporation (DAC), John Bean Technologies Corporation (JBT) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. eXp World Holdings (EXPI)

52.3% sales growth and 51.45% return on equity

eXp World Holdings, Inc. provides cloud-based real estate brokerage services for residential homeowners and homebuyers in the United States, Canada, the United Kingdom, Australia, South Africa, Portugal, France, Mexico, and India.

eXp World Holdings’s sales growth this year is expected to be 93.4% and 34.1% for next year.

Year-on-year quarterly revenue growth grew by 182.8%, now sitting on 2.76B for the twelve trailing months.

Volume

Today’s last reported volume for eXp World Holdings is 1379970 which is 36.94% above its average volume of 1007660.

eXp World Holdings’s sales growth for the next quarter is 52.3%. The company’s growth estimates for the ongoing quarter and the next is 10% and 100%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 51.45%.

Volatility

eXp World Holdings’s last day, last week, and last month’s current volatility was 7.80%, 3.28%, and 2.96%, respectively.

eXp World Holdings’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.95% (day), 4.93% (last week), and 5.43% (last month), respectively.

eXp World Holdings’s Stock Yearly Top and Bottom Value

eXp World Holdings’s stock is valued at $48.18 at 16:24 EST, way below its 52-week high of $90.00 and way higher than its 52-week low of $19.92.

eXp World Holdings’s Moving Average

eXp World Holdings’s worth is above its 50-day moving average of $46.49 and way above its 200-day moving average of $39.71.

2. Danaos Corporation (DAC)

49.4% sales growth and 56.75% return on equity

Danaos Corporation’s sales growth this year is anticipated to be 32.6% and 22.4% for next year.

Year-on-year quarterly revenue growth grew by 25.3%, now sitting on 517.13M for the twelve trailing months.

Volume

Today’s last reported volume for Danaos Corporation is 240009 which is 32.62% below its average volume of 356242.

Danaos Corporation’s sales growth is a negative 0% for the current quarter and 49.4% for the next. The company’s growth estimates for the current quarter and the next is 92.7% and 76.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 56.75%.

Volatility

Danaos Corporation’s last day, last week, and last month’s current volatility was 0.43%, 2.71%, and 2.35%, respectively.

Danaos Corporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.43% (day), 4.57% (last week), and 4.78% (last month), respectively.

Danaos Corporation’s Stock Yearly Top and Bottom Value

Danaos Corporation’s stock is valued at $77.87 at 16:24 EST, way under its 52-week high of $89.41 and way higher than its 52-week low of $5.79.

Danaos Corporation’s Moving Average

Danaos Corporation’s worth is under its 50-day moving average of $79.18 and way higher than its 200-day moving average of $65.74.

3. John Bean Technologies Corporation (JBT)

22.8% sales growth and 17.19% return on equity

John Bean Technologies Corporation provides technology solutions to food and beverage industry and equipment and services to air transportation industries.

John Bean Technologies Corporation’s sales growth this year is expected to be 12% and 10.4% for next year.

Year-on-year quarterly revenue growth declined by 8.7%, now sitting on 1.69B for the twelve trailing months.

Volume

Today’s last reported volume for John Bean Technologies Corporation is 226690 which is 29% above its average volume of 175728.

John Bean Technologies Corporation’s sales growth for the next quarter is 22.8%. The company’s growth estimates for the present quarter and the next is 45.8% and 46.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.19%.

Volatility

John Bean Technologies Corporation’s last day, last week, and last month’s current volatility was 2.47%, 0.89%, and 1.16%, respectively.

John Bean Technologies Corporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.86% (day), 2.97% (last week), and 2.48% (last month), respectively.

John Bean Technologies Corporation’s Stock Yearly Top and Bottom Value

John Bean Technologies Corporation’s stock is valued at $159.20 at 16:24 EST, below its 52-week high of $160.10 and way above its 52-week low of $80.74.

John Bean Technologies Corporation’s Moving Average

John Bean Technologies Corporation’s worth is higher than its 50-day moving average of $145.37 and way above its 200-day moving average of $140.30.

4. Regeneron Pharmaceuticals (REGN)

18.3% sales growth and 33.21% return on equity

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide.

Regeneron Pharmaceuticals’s sales growth this year is anticipated to be 56.3% and a negative 10.8% for next year.

Year-on-year quarterly revenue growth grew by 38.3%, now sitting on 9.01B for the twelve trailing months.

Volume

Today’s last reported volume for Regeneron Pharmaceuticals is 486847 which is 36.94% below its average volume of 772039.

Regeneron Pharmaceuticals’s sales growth for the next quarter is 18.3%. The company’s growth estimates for the ongoing quarter and the next is 7.7% and 8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.21%.

Volatility

Regeneron Pharmaceuticals’s last day, last week, and last month’s current volatility was 0.57%, 1.02%, and 1.09%, respectively.

Regeneron Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.18% (day), 2.13% (last week), and 2.68% (last month), respectively.

Regeneron Pharmaceuticals’s Stock Yearly Top and Bottom Value

Regeneron Pharmaceuticals’s stock is valued at $647.06 at 16:24 EST, under its 52-week high of $686.62 and way above its 52-week low of $441.00.

Regeneron Pharmaceuticals’s Moving Average

Regeneron Pharmaceuticals’s value is higher than its 50-day moving average of $644.80 and way higher than its 200-day moving average of $549.37.

Previous days news about Regeneron Pharmaceuticals(REGN)

  • According to MarketWatch on Friday, 24 September, "Shares of Regeneron Pharmaceuticals Inc. were down 0.1% in premarket trading on Friday after the World Health Organization recommended its monoclonal antibody as a treatment for COVID-19. "
  • According to Bloomberg Quint on Saturday, 25 September, "The World Health Organization on Friday recommended a combination of neutralizing monoclonal antibodies — casirivimab and imdevimab — developed by Regeneron Pharmaceuticals Inc. for treating Covid patients at the highest risk of severe disease, and urged drugmakers and governments to address the high price and limited production of the medication."

5. Century Communities (CCS)

17.1% sales growth and 27.59% return on equity

Century Communities, Inc., together with its subsidiaries, engages in the design, development, construction, marketing, and sale of single-family attached and detached homes.

Century Communities’s sales growth this year is expected to be 35% and 12.2% for next year.

Year-on-year quarterly revenue growth grew by 34.3%, now sitting on 3.83B for the twelve trailing months.

Volume

Today’s last reported volume for Century Communities is 390023 which is 0.61% below its average volume of 392425.

Century Communities’s sales growth for the next quarter is 17.1%. The company’s growth estimates for the ongoing quarter and the next is 132.4% and 40%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.59%.

Volatility

Century Communities’s last day, last week, and last month’s current volatility was 8.56%, 2.71%, and 1.95%, respectively.

Century Communities’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.60% (day), 2.73% (last week), and 3.27% (last month), respectively.

Century Communities’s Stock Yearly Top and Bottom Value

Century Communities’s stock is valued at $64.25 at 16:24 EST, way under its 52-week high of $83.20 and way above its 52-week low of $37.22.

Century Communities’s Moving Average

Century Communities’s value is below its 50-day moving average of $68.69 and below its 200-day moving average of $67.64.

6. The Ensign Group (ENSG)

10% sales growth and 23.19% return on equity

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses.

The Ensign Group’s sales growth this year is expected to be 9.2% and 8.4% for next year.

Year-on-year quarterly revenue growth grew by 6.4%, now sitting on 2.44B for the twelve trailing months.

Volume

Today’s last reported volume for The Ensign Group is 195019 which is 10.86% above its average volume of 175909.

The Ensign Group’s sales growth for the next quarter is 10%. The company’s growth estimates for the current quarter and the next is 15.4% and 18.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.19%.

Volatility

The Ensign Group’s last day, last week, and last month’s current volatility was 1.19%, 1.31%, and 1.09%, respectively.

The Ensign Group’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.09% (day), 3.84% (last week), and 2.62% (last month), respectively.

The Ensign Group’s Stock Yearly Top and Bottom Value

The Ensign Group’s stock is valued at $77.13 at 16:24 EST, way below its 52-week high of $98.66 and way above its 52-week low of $54.17.

The Ensign Group’s Moving Average

The Ensign Group’s value is under its 50-day moving average of $81.06 and below its 200-day moving average of $85.54.

7. W.R. Grace & Co. (GRA)

7.8% sales growth and 7.16% return on equity

W. R. Grace & Co., through its subsidiaries, produces and sells specialty chemicals and materials worldwide.

W.R. Grace & Co.’s sales growth this year is expected to be 11.5% and 6.6% for next year.

Year-on-year quarterly revenue growth grew by 8.4%, now sitting on 1.76B for the twelve trailing months.

Volume

Today’s last reported volume for W.R. Grace & Co. is 1111710 which is 97.03% above its average volume of 564233.

W.R. Grace & Co.’s sales growth for the next quarter is 7.8%. The company’s growth estimates for the present quarter and the next is 76.8% and 29.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.16%.

Volatility

W.R. Grace & Co.’s last day, last week, and last month’s current volatility was 0.04%, 0.02%, and 0.04%, respectively.

W.R. Grace & Co.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.06% (day), 0.06% (last week), and 0.13% (last month), respectively.

W.R. Grace & Co.’s Stock Yearly Top and Bottom Value

W.R. Grace & Co.’s stock is valued at $69.99 at 16:24 EST, below its 52-week high of $70.00 and way higher than its 52-week low of $38.70.

W.R. Grace & Co.’s Moving Average

W.R. Grace & Co.’s value is above its 50-day moving average of $69.62 and higher than its 200-day moving average of $67.28.

8. CrossFirst Bankshares (CFB)

5.6% sales growth and 7.02% return on equity

CrossFirst Bankshares, Inc. operates as the bank holding company for CrossFirst Bank that provides various banking and financial services to businesses, business owners, professionals, and its personal networks.

CrossFirst Bankshares’s sales growth this year is expected to be 8.6% and 2.4% for next year.

Year-on-year quarterly revenue growth grew by 87.1%, now sitting on 146.53M for the twelve trailing months.

Volume

Today’s last reported volume for CrossFirst Bankshares is 39824 which is 60.27% below its average volume of 100254.

CrossFirst Bankshares’s sales growth for the next quarter is 5.6%. The company’s growth estimates for the ongoing quarter and the next is 100% and 100%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.02%.

Volatility

CrossFirst Bankshares’s last day, last week, and last month’s current volatility was 0.40%, 1.59%, and 1.58%, respectively.

CrossFirst Bankshares’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.08% (day), 3.19% (last week), and 2.96% (last month), respectively.

CrossFirst Bankshares’s Stock Yearly Top and Bottom Value

CrossFirst Bankshares’s stock is valued at $12.68 at 16:24 EST, way below its 52-week high of $15.67 and way higher than its 52-week low of $8.25.

CrossFirst Bankshares’s Moving Average

CrossFirst Bankshares’s value is under its 50-day moving average of $12.95 and below its 200-day moving average of $13.93.

LEAVE A REPLY

Please enter your comment!
Please enter your name here